Group One Trading
GEVA

Group One Trading’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Group One Trading’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,677
Closed -$359K – 5550
2015
Q1 		$359K Buy
+3,677
New +$389K 0.01% 1883
2014
Q4 		– Sell
-4,420
Closed -$349K – 5734
2014
Q3 		$304K Sell
4,420
-6,991
-61% -$501K ﹤0.01% 2030
2014
Q2 		$1.2M Buy
11,411
+6,821
+149% +$580K 0.02% 1014
2014
Q1 		$381K Buy
4,590
+1,833
+66% +$169K 0.01% 1872
2013
Q4 		$178K Sell
2,757
-4,643
-63% -$276K ﹤0.01% 2544
2013
Q3 		$468K Buy
+7,400
New +$364K 0.01% 1661

Group One Trading's GEVA Position: Q2 2015 in Review

Group One Trading sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,677 shares — an estimated $359K sold.

Group One Trading first reported a position in GEVA in Q3 2013 and held it in 6 quarters. The position peaked at $1.2M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Group One Trading reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Group One Trading sold 3,677 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $359K.
  • Group One Trading first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q3 2013 and held it in 6 quarters.
  • Group One Trading's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.2M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Group One Trading's 13F filing for Q2 2015, filed 11 Aug 2015.